Non-invasive analysis of methylated cell free DNA in necrotizing enterocolitis

坏死性小肠结肠炎甲基化细胞游离 DNA 的无创分析

基本信息

  • 批准号:
    10704229
  • 负责人:
  • 金额:
    $ 58.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-08-12 至 2025-05-31
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract Necrotizing enterocolitis (NEC) is a devastating complication of prematurity that develops suddenly and carries significant morbidity and a high mortality rate for which no biomarkers exist. The high mortality rate seen in NEC could likely be prevented if there was a screening method that permitted early disease detection. Predictive and prognostic tools for NEC are essential to advance our biological insight with a view towards non-invasive detection and accurate and timely phenotyping. We have developed a NEC Biorepository with a variety of specimen types and extensive clinical metadata obtained prospectively from premature infants before the development of NEC. These samples allow us to interrogate the mechanisms that underlie NEC development, including genetic or environmental factors. These factors include epigenetic mechanisms that regulate important aspects of cellular differentiation and gut development. Importantly, the epigenetic mechanisms, specifically, at the level of DNA methylation that take place during neonatal NEC are unknown. Our preliminary epigenomic data demonstrate that numerous biological pathways are altered during NEC. Based on these findings, we now hypothesize that non-invasive identification of methylation signatures can identify an infant at risk for necrotizing enterocolitis. We will test this hypothesis by defining and quantifying the DNA methylation signatures in stool and blood of premature infants before, during and after the development of NEC. Moreover, we will expand on our observations that dysregulation of multiple key pathways is a defining pathogenic feature of NEC and use our mouse model to gain additional mechanistic insights into NEC pathobiology. By the conclusion of the proposal, we will have generated a considerable amount of genomic data from infants across the time course of development and manifestation of NEC, and also during the normal extrauterine development of preterm infants. These studies will advance our understanding of the epigenomic regulation of the pathways involved during NEC development, and furthermore, may explain the unique susceptibility of the premature infant to NEC and identify a non-invasive approach to diagnosing this devastating disease.
项目摘要/摘要 坏死性小肠结肠炎(NEC)是早产儿的一种破坏性并发症,它突然发展并携带 发病率高,死亡率高,没有生物标记物。NEC的高死亡率 如果有一种筛查方法可以及早发现疾病,那么这种疾病很可能会被预防。预测性和 NEC的预后工具对于促进我们的生物学洞察力以期实现非侵入性至关重要 检测和准确、及时的表型鉴定。我们已经开发了一种NEC生物库,其中包含各种 样本类型和大量临床数据前瞻性地从早产儿中获得 NEC的发展。这些样本让我们能够询问NEC发展的基础机制, 包括遗传或环境因素。这些因素包括表观遗传机制,它调节重要的 细胞分化和肠道发育的各个方面。重要的是,表观遗传机制,特别是 新生儿NEC期间发生的DNA甲基化水平尚不清楚。我们的初步表观基因组学 数据表明,在NEC过程中,许多生物通路发生了变化。基于这些发现,我们现在 假设甲基化特征的非侵入性识别可以识别有坏死性风险的婴儿 小肠结肠炎。我们将通过定义和量化粪便和粪便中的DNA甲基化特征来检验这一假设 早产儿发生NEC前、中、后的血液分析。此外,我们将扩大我们的 观察到多个关键通路的失调是NEC的一个决定性的致病特征,并使用我们的 小鼠模型,以获得对NEC病理生物学的更多机械见解。在提案结束时, 我们将从婴儿身上产生大量的基因组数据,时间跨度为 NEC的发生和表现,以及早产儿正常宫外发育。 这些研究将促进我们对NEC过程中涉及的通路的表观基因组调控的理解 发育,此外,可以解释早产儿对NEC的独特易感性,并确定 一种诊断这种毁灭性疾病的非侵入性方法。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Microfluidic Model of Necrotizing Enterocolitis Incorporating Human Neonatal Intestinal Enteroids and a Dysbiotic Microbiome.
结合人类新生儿肠肠类和失调微生物组的坏死性小肠结肠炎的微流体模型。
  • DOI:
    10.3791/65605
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Frazer,LaurenC;Yamaguchi,Yukihiro;Jania,CoreyM;Lanik,WyattE;Gong,Qingqing;Singh,DhirendraK;Mackay,Stephen;Akopyants,NataliaS;Good,Misty
  • 通讯作者:
    Good,Misty
Dilemmas in feeding infants with intestinal failure: a neonatologist's perspective.
  • DOI:
    10.1038/s41372-022-01504-4
  • 发表时间:
    2023-01
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    Hair, Amy B.;Good, Misty
  • 通讯作者:
    Good, Misty
Necrotizing enterocolitis: Bench to bedside approaches and advancing our understanding of disease pathogenesis.
坏死性小肠结肠炎:长凳到床边的方法,并促进我们对疾病发病机理的理解。
  • DOI:
    10.3389/fped.2022.1107404
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    2.6
  • 作者:
  • 通讯作者:
Identification of serum biomarkers for necrotizing enterocolitis using aptamer-based proteomics.
  • DOI:
    10.3389/fped.2023.1184940
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    2.6
  • 作者:
  • 通讯作者:
Dilemmas in human milk fortification.
  • DOI:
    10.1038/s41372-022-01502-6
  • 发表时间:
    2023-01
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    Hair, Amy B.;Scottoline, Brian;Good, Misty
  • 通讯作者:
    Good, Misty
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MISTY L GOOD其他文献

MISTY L GOOD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MISTY L GOOD', 18)}}的其他基金

Neonatal gut-on-a-chip platform for high content drug testing and precision medicine
用于高内涵药物测试和精准医学的新生儿肠道芯片平台
  • 批准号:
    10594705
  • 财政年份:
    2022
  • 资助金额:
    $ 58.99万
  • 项目类别:
Neonatal gut-on-a-chip platform for high content drug testing and precision medicine
用于高内涵药物测试和精准医学的新生儿肠道芯片平台
  • 批准号:
    10491072
  • 财政年份:
    2022
  • 资助金额:
    $ 58.99万
  • 项目类别:
Neonatal gut-on-a-chip platform for high content drug testing and precision medicine
用于高内涵药物测试和精准医学的新生儿肠道芯片平台
  • 批准号:
    10674890
  • 财政年份:
    2022
  • 资助金额:
    $ 58.99万
  • 项目类别:
Non-invasive analysis of methylated cell free DNA in necrotizing enterocolitis
坏死性小肠结肠炎甲基化细胞游离 DNA 的无创分析
  • 批准号:
    10577705
  • 财政年份:
    2021
  • 资助金额:
    $ 58.99万
  • 项目类别:
Non-invasive analysis of methylated cell free DNA in necrotizing enterocolitis
坏死性小肠结肠炎甲基化细胞游离 DNA 的无创分析
  • 批准号:
    10316733
  • 财政年份:
    2021
  • 资助金额:
    $ 58.99万
  • 项目类别:
Modulation of the Intestinal Immune Response in Necrotizing Enterocolitis
坏死性小肠结肠炎肠道免疫反应的调节
  • 批准号:
    10543597
  • 财政年份:
    2018
  • 资助金额:
    $ 58.99万
  • 项目类别:
Modulation of the Intestinal Immune Response in Necrotizing Enterocolitis
坏死性小肠结肠炎肠道免疫反应的调节
  • 批准号:
    10468084
  • 财政年份:
    2018
  • 资助金额:
    $ 58.99万
  • 项目类别:
Modulation of the Intestinal Immune Response in Necrotizing Enterocolitis
坏死性小肠结肠炎肠道免疫反应的调节
  • 批准号:
    10001502
  • 财政年份:
    2018
  • 资助金额:
    $ 58.99万
  • 项目类别:
Aryl hydrocarbon receptor signaling in the pathogenesis of necrotizing enterocolitis
坏死性小肠结肠炎发病机制中的芳基烃受体信号传导
  • 批准号:
    9220912
  • 财政年份:
    2017
  • 资助金额:
    $ 58.99万
  • 项目类别:
Novel Anti-Inflammatory Properties of Breast Milk in Necrotizing Enterocolitis
母乳在坏死性小肠结肠炎中的新型抗炎特性
  • 批准号:
    8820360
  • 财政年份:
    2014
  • 资助金额:
    $ 58.99万
  • 项目类别:

相似海外基金

RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 58.99万
  • 项目类别:
    Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 58.99万
  • 项目类别:
    Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 58.99万
  • 项目类别:
    Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 58.99万
  • 项目类别:
    Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 58.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 58.99万
  • 项目类别:
    Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 58.99万
  • 项目类别:
    Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
  • 批准号:
    2301846
  • 财政年份:
    2023
  • 资助金额:
    $ 58.99万
  • 项目类别:
    Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 58.99万
  • 项目类别:
    Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
  • 批准号:
    23K16076
  • 财政年份:
    2023
  • 资助金额:
    $ 58.99万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了